Fukangren is committed to the research and development of new drugs and the consistency evaluation of generic drugs. It has a strong team of highly educated core personnel with rich experience in new drug R&D and industrialization.
Beijing Fukangren Biopharmaceutical Technology Co., Ltd. started its drug R&D service in 1999 and is the CRO company with the longest continuous service time in China. Owns 3 pharmaceutical R&D centers, 1 clinical R&D center, 4 API production bases and 1 preparation production base
Solve medication difficulties through anhydrous administration and improve compliance.
Applicable varieties:
Children's medications, psychotropic drugs, ED and other tadalafil, desloratadine, levocetirizine, olanzapine, perampanel, loperamide, etc.
Innovative inhalation preparation
Clinical advantages:
Local medication has good effect and low side effects.
Applicable varieties:
New compound inhalation preparation.
Innovative multi-cavity bag technology platform
Clinical advantages:
Efficient nutritional support, easy to use, and low side effects.
Applicable varieties:
The new therapeutic formula parenteral nutrition products can develop multi-cavity bag products containing different types and concentrations of amino acids, fat emulsions and other nutritional drugs according to clinical needs.
Drug-loaded emulsion
Clinical advantages:
The drug is wrapped in milk droplets, with high stability, good safety and easy absorption.
Applicable varieties:
Conazole products such as itraconazole injection (emulsion), voriconazole injection (emulsion), carbamazepine injection (emulsion).